Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic disease or stroke

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6930089
APP PUB NO 20030054995A1
SERIAL NO

10182359

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Vascular endothelial growth factor, placenta growth factor or combinations of both including heteodimers are useful in the treatment or prevention of stroke or ischemic diseases in mammals.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
FLANDERS INTERUNIVERSITY INSTITUTE FOR BIOTECHNOLOGY (VIB)RIJVISSCHESTRAAT 120 B-9052 ZWIJNAARDE
D COOLEN RESEARCH FOUNDATION VZWONDERWIJS EN NAVORSING CAMPUS GASTUISBERG K U LEUVEN HERESTRAAT 49 B-3000 LEUVEN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Carmeliet, Peter Oud-Heverlee, BE 50 274

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation